Logo

Bayer

Ginkgo Bioworks to Acquire Zymergen for $300M in Stock

Separately, Ginkgo said it will acquire Bayer's West Sacramento, California R&D site for $83 million and has entered a multi-year collaboration with the firm.

NCCN Publishes First Guidelines for Pediatric Brain Cancer, Recommends Broad NGS Profiling

The guidelines recognize the importance of molecular profiling in diagnosing, treating, and identifying clinical trial opportunities for children with high-grade gliomas. 

Illumina Adds CDx Indication to European TruSight Oncology Test for NTRK Gene Fusion Detection

The CDx pan-cancer indication will allow the identification of patients with NTRK gene fusions who may benefit from therapy with Bayer's Vitrakvi (larotrectinib).

Ginkgo Bioworks Q1 Revenues More Than Triple

The Boston-based synthetic biology and biosecurity firm beat the consensus Wall Street revenue estimate but missed on the bottom line.

Precision Cancer Consortium Launches With Bayer, GSK, Roche, Novartis as Founding Members

The organization of pharmaceutical and biotechnology firms aims to increase access to genomic testing for cancer patients.

Nov 12, 2021

In Brief This Week: Caris Life Sciences, Psomagen, Tempus, CareDx, HTG Molecular, Epigenomics, More

Dec 22, 2020

Bayer, Veracyte to Identify Therapy-Resistant Thyroid Cancer Patients

Dec 10, 2020

Tempus Raises $200M in Series G2, Inks Oncology Testing Collaboration With Bayer

Oct 26, 2020

FDA Approves Foundation Medicine CDx, Bayer's Vitrakvi for NTRK Patients

May 14, 2020

ArcherDx, Bayer Partner on NGS-Based Companion Diagnostic Test Development

May 5, 2020

Bayer, NeoGenomics Launch Free NTRK Fusion Testing Program

Apr 30, 2020

Bayer, OrigiMed Form Companion Diagnostic Development Alliance

Sep 23, 2019

Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines
Premium

May 29, 2019

Bayer, Foundation Medicine Partner on NGS-Based Companion Diagnostic Test Development

Apr 26, 2019

European Project Aims to Develop Tools, Guidelines to Improve Data Sharing, Access
Premium

Apr 2, 2019

Bayer, Loxo Next-Generation TRK Inhibitor Shows Promising Activity in AACR Study
Premium

Nov 27, 2018

Loxo's Pan-Cancer Drug Garners FDA Approval for Patients With NTRK Fusions

Oct 31, 2018

Bayer Rolling Out Portal for Translational Research Data Sharing
Premium

Jun 29, 2018

Bayer, Broad Institute Expand Cardiovascular Disease Research Alliance

Dec 14, 2017

Ginkgo Bioworks Raises $275M to Support Foundry, Bayer Ag Venture

Nov 27, 2017

European Consortium Aims to Deliver New Tests, Therapies for Cardiovascular Diseases
Premium

Oct 3, 2017

Ginkgo Bio Invests $10M in Transcriptic, Inks Supply Deal With Twist Bioscience

Dec 21, 2016

Bayer, Leica Biosystems Collaborate on CDx for Cancer Therapies

Jul 18, 2016

T2 Biosystems, Bayer Ink Hemostasis R&D Deal

May 17, 2016

Bayer Inks CRISPR Patent Licensing Agreement

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.